Back to search results

Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis

Abroad (travel likely)RecruitingPHASE1

Conditions

Cystic Fibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Canberra Hospital, Canberra, Australian Capital Territory, Australia

    Contact: Study coordinator (Yashneel Prasad, MD)
    Contact: Study coordinator (Joelle Bourke)

  • Westmead Hospital, Westmead, New South Wales, Australia

    Contact: Study coordinator (Jimmy Chien, MD)
    Contact: Study coordinator (Tracey Burns)

  • The Prince Charles Hospital, Brisbane, Queensland, Australia

    Contact: Study coordinator (Ieuan Evans, MD)
    Contact: Study coordinator (Michelle Wood)

  • Monash Medical Centre, Clayton, Victoria, Australia

    Contact: Study coordinator (Christopher Daley, MD)
    Contact: Study coordinator (Corinne Van Asha)

  • New Zealand Clinical Research, Christchurch, New Zealand

    Contact: Study coordinator (Cory Sellwood, MD)
    Contact: Study coordinator (David Lee)
Study leads

  • Martin Burke, MD, PhD

    Study Chair

    Founder of cystetic Medicines

View source on ClinicalTrials.gov(opens in a new tab)